Research Article
Ezetimibe Attenuates Oxidative Stress and Neuroinflammation via the AMPK/Nrf2/TXNIP Pathway after MCAO in Rats
Figure 3
Eze reduced brain infraction and improved neurological outcomes at 24 h after MCAO. (a–c) Intranasal administration of Eze reduced infarction volume and improved the Garcia score at 24 h after MCAO. (d) There were no differences in beam walking scores between the MCAO groups. vs. sham, vs. vehicle, and & vs. Eze 250 μg/kg. per group. Eze: Ezetimibe.
(a) |
(b) |
(c) |
(d) |